Tresperimus

This classification denotes an immunosuppressant with the molecular formula C17H37N7O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 286F595V8H, chemically known as carbamic acid, (4-((3-aminopropyl)amino)butyl)-, 2-((6-((aminoiminomethyl)amino)hexyl)amino)-2-oxoethyl ester but more generally known as tresperimus, which bears US NIH Compound Identifier 3086680. European Medicines Agency schedules Tresperimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11241MIG. The term TRESPERIMUS is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). TRESPERIMUS is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tresperimus under HS 29252900 and SITC 51482. As of Q4 2014, TRESPERIMUS remains US FDA's Preferred Term for this commodity. Tresperimus bears US NLM identifiers UMLS ID C0528277 and NCI Concept Code C66626. SMILES: O(CC(=O)NCCCCCC/N=C(/N)N)C(=O)NCCCCNCCCN.